compound 20 [PMID: 23489211]   Click here for help

GtoPdb Ligand ID: 8124

Synonyms: PCM126 [1]
Compound class: Synthetic organic
Comment: Compound 20 is a L-tryptophan conjugate of lithocholic acid. It was developed as a non-peptide pharmacological tool for the study of ephrin (Eph) receptor activity. Compound 20 inhibits all ephrin (Eph) receptors tested, with a slight EphA preference [1]. This suggests a common binding site across the EphA and EphB receptor families [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 9
Topological polar surface area 102.42
Molecular weight 562.38
XLogP 9.51
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC1CCC2(C(C1)CCC1C2CCC2(C1CCC2C(CCC(=O)NC(C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
Isomeric SMILES O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
InChI InChI=1S/C35H50N2O4/c1-21(8-13-32(39)37-31(33(40)41)18-22-20-36-30-7-5-4-6-25(22)30)27-11-12-28-26-10-9-23-19-24(38)14-16-34(23,2)29(26)15-17-35(27,28)3/h4-7,20-21,23-24,26-29,31,36,38H,8-19H2,1-3H3,(H,37,39)(H,40,41)/t21-,23-,24-,26+,27-,28+,29+,31+,34+,35-/m1/s1
InChI Key ITOFPJRDSCGOSA-KZLRUDJFSA-N
Bioactivity Comments
We have tagged the EphA1 interaction as the primary target, as this has the only data derived from a human EphA receptor.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
EPH receptor A6 Mm Inhibitor Inhibition 5.8 pIC50 - 1
pIC50 5.8 (IC50 1.5x10-6 M) [1]
EPH receptor A8 Mm Inhibitor Inhibition 5.8 pIC50 - 1
pIC50 5.8 (IC50 1.5x10-6 M) [1]
EPH receptor A7 Mm Inhibitor Inhibition 5.7 pIC50 - 1
pIC50 5.7 (IC50 2.1x10-6 M) [1]
EPH receptor A2 Mm Inhibitor Inhibition 5.7 pIC50 - 1
pIC50 5.7 (IC50 2.2x10-6 M) [1]
EPH receptor A1 Primary target of this compound Hs Inhibitor Inhibition 5.6 pIC50 - 1
pIC50 5.6 (IC50 2.3x10-6 M) [1]
EPH receptor A5 Rn Inhibitor Inhibition 5.6 pIC50 - 1
pIC50 5.6 (IC50 2.4x10-6 M) [1]
EPH receptor A3 Mm Inhibitor Inhibition 5.6 pIC50 - 1
pIC50 5.6 (IC50 2.5x10-6 M) [1]
EPH receptor A4 Mm Inhibitor Inhibition 5.6 pIC50 - 1
pIC50 5.6 (IC50 2.7x10-6 M) [1]
EPH receptor B1 Rn Inhibitor Inhibition 5.4 pIC50 - 1
pIC50 5.4 (IC50 3.8x10-6 M) [1]
EPH receptor B2 Mm Inhibitor Inhibition 5.4 pIC50 - 1
pIC50 5.4 (IC50 3.8x10-6 M) [1]
EPH receptor B3 Mm Inhibitor Inhibition 5.4 pIC50 - 1
pIC50 5.4 (IC50 4.4x10-6 M) [1]
EPH receptor B4 Mm Inhibitor Inhibition 5.4 pIC50 - 1
pIC50 5.4 (IC50 4.4x10-6 M) [1]
EPH receptor B6 Mm Inhibitor Inhibition 5.2 pIC50 - 1
pIC50 5.2 (IC50 5.8x10-6 M) [1]